Medications for Adrenocortical Carcinoma
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Adrenocortical Carcinoma.
Found 1 Approved Drug for Adrenocortical Carcinoma
Lysodren
Generic Name
Mitotane
Lysodren
Generic Name
Mitotane
Form: Tablet
Method of administration: Oral
FDA approval date: October 15, 1978
LYSODREN is indicated for the treatment of patients with inoperable, functional or nonfunctional, adrenal cortical carcinoma. LYSODREN is an adrenal cytotoxic agent indicated for the treatment of inoperable, functional or nonfunctional, adrenal cortical carcinoma.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances